Home

SARS-CoV-2 does not stop pharmacologists

Editorial
The second 2021 issue of Pharmadvances is a cornucopia of state-of-the-art papers covering several aspects of modern-day Pharmacology. During this ...
More

Vitamin D in the COVID-19 prevention and treatment: emerging evidence

Opinion Paper
The significantly higher incidence of COVID-19 on mortality and morbidity observed in the northern Italian regions as compared to the southern ones...
More

Cancer Pharmacogenetics: perspective on newly discovered and implemented predictive biomarkers

Review
Implementation of pharmacogenetics (PGx) in the clinical practice of cancer therapy is one of the goals for a precision medicine. For some anticanc...
More

Cannabidiol and the central nervous system: translating into clinics

Review
Cannabis plants contain more than a hundred cannabinoids of which we have only limited knowledge about their effects and exact mechanisms of action...
More

Preclinical models in Oncological Pharmacology: limits and advantages

Review
A wide range of experimental tumour models, each with distinct advantages and disadvantages, is nowadays available. Due to the inherent differences...
More

The pharmacological basis of the curcumin nutraceutical uses: an update

Review
Curcumin is the major phytoconstituent found in the rhizomes of Curcuma longa L. Preparations derived from the rhizome of the plant, referred as tu...
More

Increase in Vitamin D prescriptions in a Southern Italy region over 2011-2015 period

Original Article
Cholecalciferol is the main dietary form of vitamin D. Its synthesis depends on the intensity of the ultraviolet radiation. Since endogenous vitami...
More